Detection of serum anti-ganglioside antibodies by latex agglutination assay in Guillain-Barré syndrome: comparison with ELISA.

PubWeight™: 1.40‹?› | Rank: Top 5%

🔗 View Article (PMID 12857046)

Published in Intern Med on June 01, 2003

Authors

Sachiko Irie1, Toyokazu Saito, Naomi Kanazawa, Mieko Ogino, Yutaka Ogino, Fumihiko Sakai

Author Affiliations

1: Department of Neurology, Kitasato University School of Medicine, Sagamihara.

Articles by these authors

The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain (2005) 3.65

Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol (2010) 1.72

Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clin Invest (2003) 1.65

The Global Campaign (GC) to Reduce the Burden of Headache Worldwide. The International Team for Specialist Education (ITSE). J Headache Pain (2005) 1.52

Prevention of rotavirus-induced diarrhea by preferential secretion of IgA in breast milk via maternal administration of Lactobacillus gasseri SBT2055. J Pediatr Gastroenterol Nutr (2012) 1.47

Oral sumatriptan for migraine in children and adolescents: a randomized, multicenter, placebo-controlled, parallel group study. Cephalalgia (2013) 1.41

Evidence against strong correlation between chest symptoms and ischemic coronary changes after subcutaneous sumatriptan injection. Intern Med (2002) 1.40

Development of Atrioventricular Block and Diagnostic Value of Stored Electrograms in Patients With Sick Sinus Syndrome and Implanted Pacemaker. Circ J (2015) 1.39

Fukutin gene mutations cause dilated cardiomyopathy with minimal muscle weakness. Ann Neurol (2006) 1.34

Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients. Brain (2003) 1.27

The effect of orexin-A on the pathological mechanism in the rat focal cerebral ischemia. Neurosci Res (2010) 1.24

Slowly progressive spread of the stroke-like lesions in MELAS. Neurology (2003) 1.21

Gender differences in long-term functional outcome after first-ever ischemic stroke. Intern Med (2009) 1.18

[Anti-nMDA receptor encephalitis--clinical manifestations and pathophysiology]. Brain Nerve (2008) 1.09

Pathogenesis of stroke-like episodes in MELAS: analysis of neurovascular cellular mechanisms. Curr Neurovasc Res (2005) 1.04

Regional cerebral blood flow and cerebrovascular reactivity during chronic stage of stroke-like episodes in MELAS -- implication of neurovascular cellular mechanism. J Neurol Sci (2007) 0.99

Novel deletion mutation in GFAP gene in an infantile form of Alexander disease. Pediatr Neurol (2008) 0.99

Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations. J Neurol (2012) 0.99

A case of megalencephalic leukoencephalopathy with subcortical cysts (van der Knaap disease): molecular genetic study. Brain Dev (2003) 0.98

Progressive carotid artery stenosis with a novel tRNA phenylalanine mitochondrial DNA mutation. J Neurol Sci (2008) 0.92

Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire. Headache (2003) 0.91

Migraine disability awareness campaign in Asia: migraine assessment for prophylaxis. Headache (2008) 0.90

Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan. Amyotroph Lateral Scler (2012) 0.90

The efficacy of goshuyuto, a typical Kampo (Japanese herbal medicine) formula, in preventing episodes of headache. Curr Med Res Opin (2006) 0.90

A common mutation and a novel mutation in Japanese patients with van der Knaap disease. J Hum Genet (2003) 0.90

Acquisition protocols and correction methods for estimation of the heart-to-mediastinum ratio in 123I-metaiodobenzylguanidine cardiac sympathetic imaging. J Nucl Med (2013) 0.89

Lewy body pathology in a patient with a homozygous parkin deletion. Mov Disord (2013) 0.87

Small-cell carcinoma of the esophagus associated with a paraneoplastic neurological syndrome: a case report documenting a complete response. Jpn J Clin Oncol (2006) 0.87

LRRK2 I2020T mutation is associated with tau pathology. Parkinsonism Relat Disord (2012) 0.86

Neurovascular changes in prolonged migraine aura in FHM with a novel ATP1A2 gene mutation. J Neurol Neurosurg Psychiatry (2011) 0.86

Hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome with evidence of mitochondrial dysfunction due to a novel SLC25A15 (ORNT1) gene mutation in a Palestinian family. J Neurol Sci (2004) 0.86

A case of parkinsonism and dopa-induced severe dyskinesia associated with novel mutation in the GTP cyclohydrolase I gene. Parkinsonism Relat Disord (2011) 0.85

A case of infantile Alexander disease diagnosed by magnetic resonance imaging and genetic analysis. Brain Dev (2007) 0.85

Crucial role of the cryptic epitope SLAYGLR within osteopontin in renal crystal formation of mice. J Bone Miner Res (2011) 0.84

Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy. J Neurovirol (2007) 0.84

Effects of exercise in overweight Japanese with multiple cardiovascular risk factors. Med Sci Sports Exerc (2007) 0.84

Sniff nasal inspiratory pressure in healthy Japanese subjects: mean values and lower limits of normal. Respiration (2008) 0.83

Alterations in mRNA expression of myelin proteins in the sciatic nerves and brains of streptozotocin-induced diabetic rats. Neurochem Res (2007) 0.83

Osteopontin is dispensable for protection against high load systemic fungal infection. Int Immunopharmacol (2008) 0.82

P-glycoprotein function in peripheral blood mononuclear cells of myasthenia gravis patients treated with tacrolimus. Biol Pharm Bull (2007) 0.82

[Update on anti-NMDA receptor encephalitis]. Brain Nerve (2010) 0.82

[Neurosarcoidosis]. Nihon Rinsho (2002) 0.82

Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody. Int Immunopharmacol (2007) 0.81

Intravenous immunoglobulin for chronic residual peripheral neuropathy in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome): a multicenter, double-blind trial. J Neurol (2015) 0.81

A novel R275X mutation of the SLC25A15 gene in a Japanese patient with the HHH syndrome. Brain Dev (2006) 0.80

An infantile-juvenile form of Alexander disease caused by a R79H mutation in GFAP. Brain Dev (2005) 0.80

Occurrence of cholelithiasis and cholecystitis in amyotrophic lateral sclerosis patients with long-term tracheostomy invasive ventilation. Intern Med (2011) 0.79

Tracheostomy with invasive ventilation for ALS patients: neurologists' roles in the US and Japan. Amyotroph Lateral Scler Frontotemporal Degener (2012) 0.78

FR235222, a fungal metabolite, is a novel immunosuppressant that inhibits mammalian histone deacetylase (HDAC) II. Biological activities in animal models. J Antibiot (Tokyo) (2003) 0.78

[A case of long-term survival of a patient with infantile Alexander disease diagnosed by DNA analysis]. No To Hattatsu (2005) 0.78

Development and testing of the Japanese version of the migraine-specific quality of life instrument. Qual Life Res (2004) 0.78

Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome. Ther Apher Dial (2004) 0.78

Response to sumatriptan in headache of MELAS syndrome. Neurology (2003) 0.78

ALS Untangled No. 20: the Deanna protocol. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.77

[Examination of Staphylococcus aureus survival and growth during cheese-making process]. Shokuhin Eiseigaku Zasshi (2008) 0.77

Japanese and American ALS patient preferences regarding TIV (tracheostomy with invasive ventilation): a cross-national survey. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.77

Botulinum toxin type A for migraine prophylaxis in the Japanese population: an open-label prospective trial. Intern Med (2007) 0.77

Fulminant Guillain-Barrè syndrome after Campylobacter jejuni enteritis and anti-ganglioside antibody. Intern Med (2002) 0.77

Tacrolimus hydrate (FK506): therapeutic effects and selection of responders in the treatment of myasthenia gravis. Clin Neurol Neurosurg (2003) 0.77

A novel mutation, P126R, in a Japanese patient with HHH syndrome. Pediatr Neurol (2002) 0.77

Prevention of the cryptic epitope SLAYGLR within osteopontin does not influence susceptibility to Candida albicans infection. Antimicrob Agents Chemother (2005) 0.76

Correction: Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients. PLoS One (2016) 0.75

Natural IgG antibody with anti-β-galactosyl specificity suppressed hepatoma cell invasion in culture. Cytotechnology (2012) 0.75

A case of Guillain-Barré syndrome associated with cerebellar ataxia and positive serum anti-GD1b IgG antibody. J Neurol (2002) 0.75

Loss of DARPP-32 and calbindin in multiple system atrophy. J Neural Transm (Vienna) (2013) 0.75

Inappropriate secretion of antidiuretic hormone in a patient with chronic inflammatory demyelinating polyneuropathy. Intern Med (2005) 0.75

The relation of clinical symptoms and anti-ganglioside antibodies to MEPPs frequency increase in 8 cases of variant type Guillain-Barré syndrome. J Peripher Nerv Syst (2003) 0.75

Headache and spontaneous vertebral artery dissection. Intern Med (2002) 0.75

A case of infantile Alexander disease with a milder phenotype and a novel GFAP mutation, L90P. Brain Dev (2004) 0.75

[Palliative Care for Neurological Intractable Diseases and Home Medical Support]. Brain Nerve (2015) 0.75

Suppressive potencies of calcineurin inhibitors against the mitogen-induced blastogenesis of peripheral-blood mononuclear cells of myasthenia gravis patients. J Pharm Pharmacol (2008) 0.75

[Technical evaluation of medical practice--conversion from things to skill and art. Topics: VI. Issues on fee for medical services in 20 internal medicine fields; 11. Neurology Committee]. Nihon Naika Gakkai Zasshi (2014) 0.75

[Glial fibrillary acidic protein mutation in a Chinese girl with infantile Alexander disease]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2005) 0.75

[Guideline for the practice of headache]. Rinsho Shinkeigaku (2006) 0.75

[Migraine(basilar migraine, hemiplegic migraine, CADSIL)]. Ryoikibetsu Shokogun Shirizu (2002) 0.75

[Prophylactic treatment with botulinum toxin type A]. Nihon Rinsho (2005) 0.75

[DBS therapy for Parkinson's disease - our approach]. Rinsho Shinkeigaku (2013) 0.75

[Future issues of the multiple sclerosis treatment from a medical economic viewpoint]. Nihon Rinsho (2015) 0.75

Sapporo Fitness Club Trial (SFCT)--design, recruitment and implementation of a randomized controlled trial to test the efficacy of exercise at a fitness club for the reduction of cardiovascular risk factor--. Circ J (2004) 0.75

[Determination of medullasin levels for the diagnosis of multiple sclerosis]. Rinsho Byori (2002) 0.75

Development of a comprehensive medical recorder on a cellphone. Comput Methods Programs Biomed (2009) 0.75

Molecular genetic study in Japanese patients with Alexander disease: a novel mutation, R79L. Brain Dev (2003) 0.75

Multi-center randomized control trial of etizolam plus NSAID combination for tension-type headache. Intern Med (2007) 0.75

[Clinical guideline review: Headache]. Nihon Naika Gakkai Zasshi (2002) 0.75

[Recent progress in therapy for migraine headache]. Nihon Naika Gakkai Zasshi (2004) 0.75

[Neuropathy induced by antineoplastic drugs]. Brain Nerve (2008) 0.75

[Mitochondrial ornithine transporter deficiency]. Nihon Rinsho (2002) 0.75

Vertical gaze palsy associated with bilateral ptosis following right putaminal hemorrhage. J Stroke Cerebrovasc Dis (2007) 0.75

[Paraneoplastic neurological syndromes due to myelomas and lymphomas]. Nihon Naika Gakkai Zasshi (2008) 0.75

[Technical evaluation of medical practice--conversion from things to skill and art. Topics: V. Toward establishment of technical evaluation on medical practice; 3. Payment system for informed consent]. Nihon Naika Gakkai Zasshi (2014) 0.75

[Technical evaluation of medical practice--conversion from things to skill and art. Topics; V. Toward establishment of technical evaluation on medical practice; 4. Informed consent under unusual conditions, 1) Medical fee for the decision-making support of end of life]. Nihon Naika Gakkai Zasshi (2014) 0.75